INTERNATIONAL CANNABIS BUSINESS CONFERENCE LIFETIME ACHIEVEMENT AWARDED TO
DR. FRANJO GROTENHERMEN
It took patients 17 years to change the law in favor of medical cannabis. Dr. Franjo Grotenhermen is a MD and an internationally sought after cannabinoid-specialist, supporting Germany’s cannabis patients for over two decades.
Franjo Grotenhermen, MD, Germany, Executive Director
is a principal of the nova-Institute, Hürth (near Cologne), Germany, and chairman of the German Association for Cannabis as Medicine (ACM). Workins as a medical doctor in private practice and most patients seek a treatment with cannabis or cannabinoids. He has been a key team member to several efforts on cannabis policy in and outside of Germany, including the medical use of cannabis and cannabinoids, the potential impacts of THC residues in hemp foods, and the issue of cannabis and driving.
He is the editor of “Cannabis and Cannabinoids. Pharmacology, Toxicology and Therapeutic Potential”, published in German, English and Spanish, and “Cannabis, Straßenverkehr und Arbeitswelt” [Cannabis, Driving and Workplace] in German, and author of “Hanf als Medizin [Hemp as Medicine], published in several languages including French and Spanish.